Clinical Trial Update: Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study in healthy subjects assessing relative bioavailability, safety, tolerability, pharmacokinetics, and the effect of food on GSK2140944.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• GSK2140944

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 1 | Status: COMPLETED